Short Description

Patients receiving Infliximab drug experience loss of response to therapy during course of disease primarily due to development of antibodies to infliximab. These antibodies bind to the drug and either block their action or increase their clearance leading to loss of clinical efficacy. Monitoring the drug and its antibody levels may help to make rational therapeutic decisions in different clinical situations.

PreTest Information

No special preparation required

Detail Description

INFLIXIMAB ANTIBODY Test: Cost, Symptoms and Diagnosis in India

INFLIXIMAB ANTIBODY test is a medical procedure that is used to measure the levels of antibodies against infliximab in the blood. Infliximab is a medication that is used to treat autoimmune disorders such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, and psoriasis. The test helps in determining whether a patient is developing antibodies against the medication, which can lead to a decrease in its effectiveness.

Cost of INFLIXIMAB ANTIBODY Test in India

The cost of INFLIXIMAB ANTIBODY test in India varies depending on the location of the laboratory, the quality of the test and the experience of the technician. On average, the cost of the test ranges from INR 8,000 to INR 11,000. The test is usually covered by health insurance if it is deemed medically necessary.

Symptoms of Infliximab Antibody Development

Patients who are taking infliximab may develop antibodies against the medication, which can lead to a decrease in its effectiveness. Some of the symptoms of infliximab antibody development include:

• Increased joint pain and swelling
• Increased fatigue
• Increased skin rashes or lesions
• Increased gastrointestinal symptoms such as diarrhea

If a patient experiences any of these symptoms, they should contact their healthcare provider immediately.

Diagnosis of Infliximab Antibody Development

The diagnosis of infliximab antibody development is done through a blood test. The test measures the levels of antibodies against infliximab in the blood. A positive test result indicates that the patient has developed antibodies against the medication, which can lead to a decrease in its effectiveness.

The test is usually performed when a patient is experiencing increased symptoms or when their response to the medication is decreasing. The test may also be performed before starting infliximab treatment to determine whether the patient is at risk of developing antibodies against the medication.

Conclusion

The INFLIXIMAB ANTIBODY test is an important medical procedure that helps in determining whether a patient is developing antibodies against infliximab. The test is usually performed when a patient is experiencing increased symptoms or when their response to the medication is decreasing. Patients who are taking infliximab should be aware of the symptoms of infliximab antibody development and should contact their healthcare provider immediately if they experience any of these symptoms.

At DNA Labs India, we offer a wide range of medical tests including the INFLIXIMAB ANTIBODY test. Our team of experienced technicians and state-of-the-art equipment ensures accurate and reliable test results. Contact us today to schedule an appointment or to learn more about our services.